Paper - WANFANG MED ONLINE

You Position: Home > Paper

易损斑块的早期识别进展

( views:166, downloads:122 )

Author:: No author available

Journal Title:: China Clinical Practical Medicine

Issue:: 3

DOI:: 10.3760/cma.j.issn.1673-8799.2015.03.032

Key Word:: 动脉粥样硬化;易损斑块;早期识别

Abstract：脑血管病是常见病、多发病，严重危害人类健康，动脉粥样硬化易损斑块在其中起着重要作用。易损斑块有着特定的病理特点，如果有相应的手段前瞻性的识别易损斑块，从而允许我们及时、最早的干预治疗是非常必要的。本文就近年来对易损斑块的早期识别进行综述报告。

Reference

[1]薛蕴菁,段青.能谱计算机断层扫描成像在神经系统方面的临床应用[J].2013,(2).
[2]李玲玲,潘燕,张桂萍,等.颈动脉斑块的稳定性与脑梗死程度的临床研究[J].2012,(9).
[3]吕及晟.能谱CT在中枢神经系统疾病诊断中的应用[J].2013,(34).
[4]万杰清,李善泉,江基尧.血管内超声在颈动脉粥样硬化研究中的应用--与血管造影和组织病理学的比较研究[J].2008,(12).
[5]林晓珠,沈云,陈克敏.CT能谱成像的基本原理与临床应用研究进展[J].2011,(8).
[6]杨军,邵蕾.多层螺旋CT和彩色多普勒超声联合应用评价老年脑梗死患者颈动脉粥样硬化的价值[J].2013,(12).
[7]刘国荣,姚林,王大力.颈动脉粥样硬化斑块易损性的临床研究进展[J].2012,(7).
[8]中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].2010,(2).
[9]Morteza, Naghavi,Peter, Libby,Erling, Falk,etc.From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.[J].2003,108.
[10]Tina Lam,Ashok K Kakkar,Eric Rhéaume,etc.VCAM-1-targeting gold nanoshell probe for photoacoustic imaging of atherosclerotic plaque in mice.[J].2013,8(1).
[11]Kim, I.-S.,Lee, B.-H.,Lee, G.Y.,etc.Molecular targeting of atherosclerotic plaques by a stabilin-2-specific peptide ligand[J].2011,155(2).
[12]Winter P. M..Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With\u00a0v\u00a03-Integrin-Targeted Nanoparticles[J].2003.
[13]Wickline SA,Fischer S,Fuhrhop RJ,etc.Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques.[J].2001,104(11).
[14]Heeneman S,van der Geest RJ,Daemen MJ,etc.Gadofosveset-enhanced magnetic resonance imaging of human carotid atherosclerotic plaques: a proof-of-concept study.[J].2010,45(5).
[15]Tacelli N,Remy J,Pontana F,etc.Thoracic applications of dual energy.[J].2010,48(1).
[16]Chen,W.,Dilsizian,V..Targeted PET/CT imaging of vulnerable atherosclerotic plaques: Microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose[J].2013,15(6).
[17]Bode C,Choudhury RP,von-zur-Muhlen C,etc.Visualization of activated platelets by targeted magnetic resonance imaging utilizing conformation-specific antibodies against glycoprotein IIb/IIIa.[J].2009,46(1).
[18]Thomas, J.M.,Getz, J.A.,Ruoslahti, E.,etc.Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases[J].2012,161(3).
[19]Debatin JF,Vogt P,Kolb S,etc.Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits.[J].2001,103(3).
[20]Chan,J.M.S.,Monaco,C.,Wylezinska-Arridge,M.,etc.Imaging of the vulnerable carotid plaque: Biological targeting of inflammation in atherosclerosis using iron oxide particles and MRI[J].2014,47(5).
[21]De Vos, Jens,Mathijs, Iris,Xavier, Catarina,etc.Specific Targeting of Atherosclerotic Plaques in ApoE(-/-) Mice Using a New Camelid sdAb Binding the Vulnerable Plaque Marker LOX-1[J].2014,16(5).
[22]Aguilera, Todd A.,Jiang, Tao,Nguyen, Quyen T.,etc.In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity[J].2012,4(6).
[23]Myers KS,Sanz J,Rudd JH,etc.Multimodality imaging of atherosclerosis (magnetic resonance imaging/computed tomography/positron emission tomography-computed tomography).[J].2007,18(5).
[24]Broisat,A.,Hernot,S.,Toczek,J.,etc.Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions[J].2012,110(7).
[25]Hillebrands,J.L.,VanDam,G.M.,Razansky,D.,etc.Multispectral optoacoustic tomography of matrix metalloproteinase activity in vulnerable human carotid plaques[J].2012,14(3).
[26]Ishino S,Kuge Y,Takai N,etc.99m)Tc-Annexin A5 for noninvasive characterization of atherosclerotic lesions: imaging and histological studies in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits.[J].2007,34(6).
[27]Ballet,S.,Garot,J.,Duquesnoy,S.,etc.Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging[J].2012,9(4).
[28]Jezovnik,M.K.,Zidar,N.,Lezaic,L.,etc.Identification of inflamed atherosclerotic lesions in vivo using PET-CT[J].2014,37(2).
[29]Tahara,N.,Mukherjee,J.,DeHaas,H.J.,etc.2-deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis[J].2014,20(2).